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CASE REPORT

PROSTATE CANCER METASTASIS TO CERVICAL NODE CHAIN-AN
UNUSUAL CLINIC-PATHOLOGICAL FINDING
Haissan Iftikhar, Mubasher Ikram, Mohammad Usman Iqbal*, Shayan Khalid Ghaloo
Department of Surgery, *Department of Histopathology, Aga Khan University Hospital, Karachi-Pakistan

Prostate carcinoma is one of the most common cancers in males all around the world. Head and
neck squamous cell carcinoma is amongst the leading carcinoma (HNSCC) in men especially in
the sub-continent. There are around 150 lymph nodes on either side in the neck and cervical lymph
nodes are a common site for head and neck malignancies to metastasize however carcinoma of
prostate may in rare cases metastasize to cervical chain, therefore warranting a neck dissection. In
case of unknown primary of head and neck extensive work up is required to find the primary site.
Our case provided a similar picture with a single enlarged node which on biopsy to our surprise
revealed adenocarcinoma of prostate.
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INTRODUCTION
The cervical lymph nodes are a common site for
metastasis of cancers of head and neck. There are
approximately 300 lymph nodes in the cervical
region draining the head and neck region.1 Prostate
carcinoma is the most common non-cutaneous
malignancy in men and the 3rd most common
cause of cancer associated mortality.2 It is
commonly seen between the ages of 60-74 with its
peak incidence around the age of 65 years.2,3
Adenocarcinoma
of
prostate
occasionally
metastasizes to cervical lymph nodes, with
reported incidence ranging from 0.29–0.4.4,5
Cervical lymph node metastasis might be
a first sign of malignancy. It warrants a full
spectrum
of
diagnostics
test
including
panendoscopy under general. Metastasis from
other organs of the body may be a possibility but is
rare.

CASE REPORT
A 66-year male, diabetic and hypertensive
presented to the urology clinic with lower urinary
tract symptoms for one month which had
progressively worsened. On examination, patient
had bilateral inguinal lymphadenopathy and a node
at the left supraclavicular region. Digital rectal
examination (DRE) revealed a moderately enlarged
prostate with irregular surface and hard
consistency. Prostate specific antigen was 41.6.
Staged as T2cNxMx. CT scan abdomen, pelvis and
chest was advised which revealed widespread
inguinal,
para-aortic
and
mediastinal
lymphadenopathy with lymph nodes measuring
around one cm and no contrast enhancement seen
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in the prostate. CT-scan also revealed a relative
decreased enhancement of left kidney with mild
hydronephrosis and hydro ureter likely secondary
to entrapment of ureter by lymphadenopathy. A
left supraclavicular lymph node of the size 1.58 cm
was also picked up on the scan (Figure-1). Bone
scan revealed multiple abnormal increase tracer
deposit over sacroiliac joint, left acetabulum, left
head of femur and transverse process of T1
vertebrae. Left supraclavicular node was biopsied
which revealed metastatic adenocarcinoma of
prostate with complete effacement of nodal
architecture by metastatic tumour arranged in
sheets, nests and aggregates. (Figure-2)
Patient was diagnosed with infiltrating
Adenocarcinoma of prostate, Gleason's major 5,
minor 5, Gleason's sum 5+5=10/10 after
transurethral resection of prostate. TNM stage
T2cN1M2b. Patient denied surgical intervention
and was referred for palliative radio and
chemotherapy.

Figure-1: Left supraclavicular lymph node
measuring around 1.58cm.
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Figure-2A: Lymph node architecture is
completely effaced by nests of
metastatic tumour. Only a thin fibrous
capsule (star) at the periphery is left as
an evidence of lymph node. (H&E 100x
magnification).

Figure-2B: Tumour nests showing
occasional lumen formation. Tumour cells
have granular (stippled) chromatin and
show frequent mitotic figures (small
arrow head). (H&E 400x magnification).

Figure-2C: Tumour cells showing diffuse
strong positive expression for Cytokeratin
CAM5.2 (A), focal strong positive expression
for PSA (B) and focal positive expression for
Chromogranin A IHC stains (C). (400x
magnification).

DISCUSSION

CONCLUSION

Prostate cancer is the third most common cause of
cancer related deaths in males following lung cancer and
accounts for 14% of all male deaths.2,5 Most common
variant is adenocarcinoma and makes up to 95% of all
the cases of prostate cancer.6 Adenocarcinoma of
prostate metastasis to regional and para-aortic lymph
nodes and is postulated to spread to bones
hematogenously via the Batson’s plexus.7
There are over 300 lymph nodes in the
cervical chain and make up to 1/3rd of all the lymph
nodes of the body.1 Most common metastasis to the
cervical chain is from the head and neck region of the
squamous cell type the remaining metastatic cancers
are from the non-mucosal glands such as the skin,
thyroid and the salivary glands. A study found 5
cases out of 1367 patients autopsied to have
metastatic prostate carcinoma in cervical lymph
nodes.8 Another study reported a high prevalence of
latent carcinoma of prostate and showed up to 1/3rd
of the cases of autopsies to have carcinoma of
prostate.9 Therefore, some authors suggest work-up
for prostate cancer in patients with supraclavicular
lymph node metastasis.
The management of metastatic prostate
cancer is not of focused in this report however, its
treatment requires excision of the gland. The clinical
presence of supraclavicular lymph node indicates a
stage IV disease with a 5-year survival of 30%.2,10 The
mean survival is 30 months for metastatic prostate
cancer. Prolonged survival is reported with appropriate
and timely diagnosis and treatment of metastatic
adenocarcinoma of prostate to head and neck.

The lymph nodes dissected should undergo
immunobiological staining for a possible metastasis of
adenocarcinoma of prostate. Prostate cancer should also
be ruled out in patients with supraclavicular
lymphadenopathy over 45 years of age.6
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